ARROW PHARM (MALTA) LIMITED - NEW PHARMACEUTICAL MANUFACTURING COMPANY TO START PRODUCTION BY JUNE 2003
The Minister for Economic Services, the Hon. Prof. Josef Bonnici, chaired a press conference in which details were given concerning a new pharmaceutical manufacturing company, namely Arrow Pharm (Malta) Ltd., which is due to start fully fledged production in June this year.
This venture represents a significant, additional foreign direct investment in Malta, more specifically in the production of generic drugs. It comes in the wake of the upgrading and expansion plans announced recently by another company engaged in the same line of business, namely Pharmamed.
These very positive developments reinforce the conviction, already expressed on the part of government, that the pharmaceutical industry holds particular potential for Malta. It is also one of the niche areas that will be actively promoted by Malta Enterprise, once this new organisation is up and running.
Arrow Pharm (Malta) Ltd., is a wholly owned subsidiary of the Arrow Group, a multinational pharmaceutical company with its head office in Denmark. Arrow Pharm (Malta) Ltd. will be operating from an 8,000 square metre factory in Hal Far, allocated to them by the Malta Development Corporation, which they are now in the process of adapting and customising to their requirements. Their investment is expected to exceed Lm 3.0 million.
The refurbishment and customisation of the Hal Far factory is due to be completed by the end of April 2003, to be followed immediately by the installation and commissioning of the relevant machinery and related equipment. Trial production will commence in May, which will allow the certification of the production facilities to be carried out before June 2003, when regular production is due to commence.
The company has already recruited locally a Quality Assurance Manager and a Plant Engineer, who have been sent overseas for specialised training. Recruitment of additional personnel will commence shortly. It is expected that the company will provide employment for about 40 personnel during its first year of operation and around 200 within 5 years.
Also present for the press conference were: Dr. Anne Power, Arrow Group Technical Director; Mr. Tony Allen, Finance Director Arrow Pharm (Malta) Ltd.; Dr. Paul Harrison, Production Director Arrow Pharm (Malta) Ltd. and Mr. Paul Barker, Production Manager Arrow Pharm (Malta) Ltd.
During the press conference, Minister Bonnici explained how Malta’s potential to attract foreign direct investment would be significantly enhanced through Malta’s imminent EU membership. New opportunities will be created that Malta must be ready to tap. Hence the decision to establish Malta Enterprise that will be taking over the functions of the MDC, METCO and IPSE with the objective of delivering a more comprehensive, better integrated and more effective support service to industry in Malta. Many have identified the benefits from of a ‘one-stop-shop’ approach to industrial promotion and support services. Malta Enterprise will achieve that and more.
Enclosed with this brief hand-out is an artist’s rendition of the main entrance to the factory, as it will appear once the current refurbishment works have been completed together with the Arrow logo.
Other Press Releases:
PR261934en
PRESS RELEASE BY THE MINISTRY FOR THE ECONOMY, TECHNOLOGY AND STRATEGIC PRO...
PR261934